Mission Therapeutics Secures $13.3M to Advance First-in-Class Parkinson's Disease Drug MTX325 ...
Bestof

Mission Therapeutics Secures $13.3M to Advance First-in-Class Parkinson's Disease Drug MTX325 ...

3024 × 1494 px December 16, 2025 Peter Bestof

Mission Therapeutics Secures $13.3M to Advance First-in-Class Parkinson's Disease Drug MTX325 ... is a high-quality image in the Bestof collection, available at 3024 × 1494 pixels resolution — ideal for both digital and print use.

Understand the 5 stages of Parkinson's disease. Learn about motor symptoms, progression patterns, and daily management strategies for better care planning.

Image Details

TitleMission Therapeutics Secures $13.3M to Advance First-in-Class Parkinson's Disease Drug MTX325 ...
Dimensions3024 × 1494 px
CategoryBestof
PublishedDecember 16, 2025
AuthorZeus
Downloads678
Views2,193

Read full article: Phases Of Parkinson's Disease

// More Images